Mount Sinai Ovarian Cancer Risk Assessment Program Core Evaluation
Women who enter the program receive an extensive personal and family medical history questionnaire to complete prior to their initial visit. Appointments last one to two hours, with more time allotted as necessary.
This clinical research program is limited to the early detection of early stage ovarian cancer. Therefore, all participants entering the program must have a referring physician who will provide routine gynecologic care, such as internal examinations, Pap tests, and annual examinations. The success of the program is contingent upon collaboration and communication among the program participant, the referring physician.
The Core Evaluation includes:
- A consultation with a board certified genetic counselor
- Vaginal or abdominal ultrasound using vascular analysis, 3D or 4D image analysis and possibly contrast sonography
- Physical examination, including an internal pelvic and rectal examination
- Blood work for tumor marker experimental tests
- Psychological, social, and physical well-being studies, such as:
- Impact of Events Scale (IES)
- Profile of Mood States (POMS)
- Functional Assessment of Cancer Therapy Scale, General (FACT-G)
- Medical Outcomes Study, Short Form-36 (SF-36)
Participants are expected to return to the Program every six months for ultrasound, physical examination, and optional experimental blood work and research surveys. At each visit the participant’s personal and family medical history will be updated if changes have occurred.
The Mount Sinai Ovarian Cancer Risk Assessment Program is located in The Derald H. Ruttenberg Treatment Center in the Department of Obstetrics, Gynecology and Reproductive Science, 1475 Madison Avenue, New York, NY 10029. For more information about the Mount Sinai National Ovarian Cancer Early Detection Program, please contact: David A. Fishman, MD, email@example.com, 212-241-1111.
Mount Sinai Ovarian Cancer Risk Assessment Program